Prostate cancer is a prevalent and costly disease in the US, and the most common cancer among men. Non-surgical therapy frequently consists of androgen deprivation therapy (ADT) or radiation treatment combined with hormonal therapy. A study conducted in the US and presented at the 9th Annual ...
The treatment plan for prostate cancer depends on the size, location, extent of the disease, and the patient’s physical condition. In St. Stamford Modern Cancer Hospital Guangzhou, experts from Multidisiplinary Team (MDT) will jointly hold a consultation and discuss appropriate treatment options ...
In oncology, the Company is conducting a phase 1 clinical trial of PSMA ADC, a human monoclonal antibody-drug conjugate forthetreatmentofprostate cancer. mdsol.com mdsol.com 在肿瘤学领域,该公司正在开展 PSMA ADC 的Ⅰ期临床试验,该药是一种人类单克隆抗体-药物共轭物,用于治疗前列腺癌。
Additional studies will be needed to accurately identify the sub-categories of patients who would most benefit from this new treatment for metastatic castration-resistantprostatecancer. The article "Apalutamide plusabiraterone acetateand prednisone versus placebo plus abiraterone and prednisone in metastatic,...
therapy targeting the AR pathway has been the mainstay strategy for metastatic prostate cancer treatment. The utility of these agents has expanded with the emergence of second-generation AR antagonists, which began with the approval of enzalutamide in 2012 by the United States Food and Drug Administ...
International Journal of Molecular Sciences Review Recent Advances in Prostate Cancer Treatment and Drug Discovery Ekaterina Nevedomskaya, Simon J. Baumgart and Bernard Haendler * Therapeutic Research Groups, Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany; ...
To manage a loss of libido with prostate cancer, you can: Ask your doctor about breaks with your hormone therapy treatment, or only restart treatment when your prostate-specific antigen (PSA) levels begin to rise Talk to your doctor about drug treatment for erection problems Seek advice from ...
undetected/untreated prostate cancer. Conversely, men over 70 often have more indolent or slow-growing prostate cancers or other medical conditions that may be greater threats to their lives over the next 10 years than may prostate cancer, and thus less aggressive evaluation and treatment may be ...
undetected/untreated prostate cancer. Conversely, men over 70 often have more indolent or slow-growing prostate cancers or other medical conditions that may be greater threats to their lives over the next 10 years than may prostate cancer, and thus less aggressive evaluation and treatment may be ...
Treatment of prostate cancer increasingly involves an approach that combines local therapies directed at the primary tumour together with systemic therapies to potentiate their effect and to control subclinical metastatic disease. Patients with localised tumours who are at high risk of relapsing with radiat...